NGN Capital

NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.

Business Model:

Revenue: $5.8M

Employees: 2-10

Rankings

Detailed NGN Capital Information

Geographic Data

NGN Capital headquarters map

Address: 369 Lexington Ave

City: New York

State: NY

Zip: 10017

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

6,431,267Website Global Rank

1,372Website Monthly Traffic

Twitter Followers

Description

NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector. The fund focuses specifically on investments in the healthcare, pharmaceutical, and biotech sectors including drug products, medical devices, diagnostics, and healthcare services.

Contact Phone:
+12129720077

Contact Email:

Announced Date Company Transaction Money Raised
7/2017 Exosome Diagnostics Series C 0
8/2005 Sightline Technologies Series D 0
3/2006 EKOS Corporation Series C 0
1/2007 Tigris Pharmaceuticals Series B 16M
7/2010 Artisan Pharma Series C 0
3/2010 Valtech Cardio Series B 17.8M
11/2005 Javelin Pharmaceuticals Private Equity Round 32M
2/2005 Jerini Venture Round 20.2M
10/2006 Santhera Pharmaceuticals Series C 0
1/2016 Exosome Diagnostics Series B 0
3/2014 Exosome Diagnostics Series B 0
7/2007 BeneChill Series B 3.5M
12/2004 Santhera Pharmaceuticals Series A 0
4/2009 Aerovance Venture Round 38M
11/2013 Endosense Series C 41.2M
3/2010 Artisan Pharma Series B 22M
9/2006 Artisan Pharma Series A 39M
4/2009 Small Bone Innovations Series D 0
7/2012 Cerapedics Series C 0
5/2010 Noxxon Pharma Series D 40.7M
11/2012 Endosense Series C 40.3M
3/2007 Aerovance Series C 60M
9/2015 Exosome Diagnostics Series B 0
2/2005 EKOS Corporation Series B 0
3/2007 Nitec Pharma AG Series B 26M
12/2010 Small Bone Innovations Series F 0
1/2008 Small Bone Innovations Series C 0
12/2005 Small Bone Innovations Series B 0
1/2009 Vivaldi Biosciences Series A 23M
4/2009 Cerapedics Series B 15M
8/2004 Aerovance Series B 32M
9/2009 BeneChill Series C 13.5M
12/2005 Santhera Pharmaceuticals Series B 0
10/2008 Micromet Post-IPO Equity 0
1/2014 PIN Pharma Series A 6.8M
5/2010 Exosome Diagnostics Series A 20M
10/2005 OptiScan Biomedical Venture Round 36M
5/2008 ACT Biotech Series A 6.6M
7/2017 Exosome Diagnostics Series C 0
1/2016 Exosome Diagnostics Series B 0
9/2015 Exosome Diagnostics Series B 0
3/2014 Exosome Diagnostics Series B 0
1/2014 PIN Pharma Series A 0
11/2013 Endosense Series C 0
11/2012 Endosense Series C 0
7/2012 Cerapedics Series C 0
12/2010 Small Bone Innovations Series F 0
7/2010 Artisan Pharma Series C 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research